Dr. Kaarin Anstey
Laureate Fellow and Scientia Professor of Psychology
Professor Kaarin Anstey is an ARC Laureate Fellow and Scientia Professor of Psychology at the University of New South Wales. She is also Director of the University of New South Wales Ageing Futures Institute, and a Senior Principal Research Scientist at Neuroscience Research Australia. Anstey also co-Directs the Australian Dementia Centre for Research Collaboration and is Chair of the International Research Network on Dementia Prevention. Anstey’s research programs focus on the causes, consequences and prevention of cognitive ageing, dementia, and common mental disorders in adulthood. Dr Anstey is Principal Investigator on the PATH Through Life project which is a 20-year long population-based study focusing on risk factors for cognitive decline and dementia. Anstey is also an investigator on several multi-domain risk reduction trials. Anstey led the Body Brain Life multi-domain risk reduction trial in Primary care, is a co-investigator on the Mind Your Brain Trial and the soon to commence AU Arrow trial. She is a member of the Governance Committee of the Global Council on Brain Health and was a member of the WHO Guideline Development Committee for the guidelines on risk reduction for cognitive decline and dementia.
Laureate Fellow and Scientia Professor of Psychology
Professor Kaarin Anstey is an ARC Laureate Fellow and Scientia Professor of Psychology at the University of New South Wales. She is also Director of the University of New South Wales Ageing Futures Institute, and a Senior Principal Research Scientist at Neuroscience Research Australia. Anstey also co-Directs the Australian Dementia Centre for Research Collaboration and is Chair of the International Research Network on Dementia Prevention. Anstey’s research programs focus on the causes, consequences and prevention of cognitive ageing, dementia, and common mental disorders in adulthood. Dr Anstey is Principal Investigator on the PATH Through Life project which is a 20-year long population-based study focusing on risk factors for cognitive decline and dementia. Anstey is also an investigator on several multi-domain risk reduction trials. Anstey led the Body Brain Life multi-domain risk reduction trial in Primary care, is a co-investigator on the Mind Your Brain Trial and the soon to commence AU Arrow trial. She is a member of the Governance Committee of the Global Council on Brain Health and was a member of the WHO Guideline Development Committee for the guidelines on risk reduction for cognitive decline and dementia.
Professor Robert Howard
UCL Division of Psychiatry
Professor of Old Age Psychiatry
Robert Howard is currently Professor of Old Age Psychiatry at University College London, Honorary Consultant Old Age Psychiatrist at Camden and Islington NHS Foundation Trust, Mental Health Theme Lead and NIHR Senior Investigator at UCL Hospital, and Scientific Trustee for the Alzheimer Research UK.
During his research career, Professor Howard has studied dementia and psychotic disorders of older people where he coined the term very late-onset schizophrenia-like psychosis. He is interested in the neurobiology of hallucinations and delusions in older people with and without dementia and look for potential mechanisms for treatment. Pr Howard has lead trial teams to investigate the effectiveness of drug, psychosocial, educational and technology interventions, using practical and clinically meaningful outcome measures. Those trials have been extensively cited in relevant NICE Guidance.
UCL Division of Psychiatry
Professor of Old Age Psychiatry
Robert Howard is currently Professor of Old Age Psychiatry at University College London, Honorary Consultant Old Age Psychiatrist at Camden and Islington NHS Foundation Trust, Mental Health Theme Lead and NIHR Senior Investigator at UCL Hospital, and Scientific Trustee for the Alzheimer Research UK.
During his research career, Professor Howard has studied dementia and psychotic disorders of older people where he coined the term very late-onset schizophrenia-like psychosis. He is interested in the neurobiology of hallucinations and delusions in older people with and without dementia and look for potential mechanisms for treatment. Pr Howard has lead trial teams to investigate the effectiveness of drug, psychosocial, educational and technology interventions, using practical and clinically meaningful outcome measures. Those trials have been extensively cited in relevant NICE Guidance.